(Q34059375)

30 July 2017

1 reference

title

Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism (English)

1 reference

30 July 2017

0 references

1 reference

Bick RL

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

60

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

575-595

1 reference

A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study

30 July 2017

cites work

1 reference

12 December 2020

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

1 reference

12 December 2020

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

12 December 2020

Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting

1 reference

12 December 2020

Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis

1 reference

12 December 2020

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma

1 reference

12 December 2020

Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

1 reference

12 December 2020

Blood protein defects associated with thrombosis. Laboratory assessment.

1 reference

12 December 2020

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis

1 reference

12 December 2020

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection

1 reference

12 December 2020

Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement.

1 reference

12 December 2020

Prevention of venous thromboembolism

1 reference

12 December 2020

Deep Vein Thrombosis: Prevalence of Etiologic Factors and Results of Management in 100 Consecutive Patients

1 reference

12 December 2020

Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management

1 reference

12 December 2020

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

12 December 2020

Long-term outcomes of deep-vein thrombosis

1 reference

12 December 2020

The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence

1 reference

12 December 2020

Treatment of deep venous thrombosis and pulmonary embolism. Current recommendations

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Starting prophylaxis for venous thromboembolism postoperatively

1 reference

12 December 2020

International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997.

1 reference

12 December 2020

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

12 December 2020

Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis

1 reference

12 December 2020

A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study

1 reference

12 December 2020

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

1 reference

12 December 2020

Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis

1 reference

12 December 2020

Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendations

1 reference

12 December 2020

The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery

1 reference

12 December 2020

Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots

1 reference

12 December 2020

The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecological surgery

1 reference

12 December 2020

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

12 December 2020

Medicolegal implications of consensus statements

1 reference

12 December 2020

Low-molecular-weight heparin--an opportunity for home treatment of venous thrombosis

1 reference

12 December 2020

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy

1 reference

12 December 2020

Anticoagulant prophylaxis of thromboembolism in postsurgical patients

1 reference

12 December 2020

Diagnosis of deep venous thrombosis and pulmonary embolism

1 reference

12 December 2020

Deep vein thrombosis. Diagnosis and management.

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis

1 reference

12 December 2020

Effectiveness and safety of low molecular weight heparins (LMWH) in the prevention of venous thromboembolism (VTE)

1 reference

12 December 2020

Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis

1 reference

12 December 2020

Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures. A controlled clinical trial

1 reference

12 December 2020

Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)

1 reference

12 December 2020

Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients

1 reference

12 December 2020

"Delayed" prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties

1 reference

12 December 2020

Thrombolytic therapy. Agents, indications, and laboratory monitoring

1 reference

12 December 2020

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

12 December 2020

Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis

1 reference

12 December 2020

Ardeparin and danaparoid for prevention of deep vein thrombosis

1 reference

12 December 2020

Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin. H.B.P.M. Research Group

1 reference

12 December 2020

Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial

1 reference

12 December 2020

Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

12 December 2020

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

1 reference

12 December 2020

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial

1 reference

12 December 2020

Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK

1 reference

12 December 2020

Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

1 reference

12 December 2020

Anticoagulant prophylaxis in surgical patients

1 reference

12 December 2020

Therapy for venous thrombosis: guidelines for a competent and cost-effective approach.

1 reference

12 December 2020

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

12 December 2020

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

12 December 2020

Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin

1 reference

12 December 2020

Natural history of pulmonary embolism

1 reference

12 December 2020

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

12 December 2020

Calf deep venous thrombosis. A wolf in sheep's clothing?

1 reference

12 December 2020

Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group

1 reference

12 December 2020

A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery

1 reference

12 December 2020

Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial

1 reference

12 December 2020

Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis

1 reference

12 December 2020

Prevention of venous thrombosis with minidose warfarin after joint replacement.

1 reference

12 December 2020

Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism--can death from pulmonary embolism be prevented?

1 reference

12 December 2020

A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial

1 reference

12 December 2020

The effect of intermittently applied external pressure on the haemodynamics of the lower limb in man.

1 reference

12 December 2020

Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

12 December 2020

Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo

1 reference

12 December 2020

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

1 reference

12 December 2020

10.2165/00003495-200060030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1046492239

0 references

1 reference